Rural Health
Resources by Topic: Illicit drug use
Opioid Use Disorder: Opportunities to Improve Assessments of State Opioid Response Grant Program
Provides an overview of the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response (SOR) grant program and examines how SAMHSA assesses the program. Offers recommendations to SAMHSA to identify potential limitations in its analyses and provide a more comprehensive assessment of the program to identify opportunities for improvement. Includes SOR grant funding awards by state for fiscal years 2020 and 2021.
Additional links: Full Report
Date: 12/2021
Type: Document
Sponsoring organization: Government Accountability Office
view details
Provides an overview of the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response (SOR) grant program and examines how SAMHSA assesses the program. Offers recommendations to SAMHSA to identify potential limitations in its analyses and provide a more comprehensive assessment of the program to identify opportunities for improvement. Includes SOR grant funding awards by state for fiscal years 2020 and 2021.
Additional links: Full Report
Date: 12/2021
Type: Document
Sponsoring organization: Government Accountability Office
view details
A Cross-Sectional Survey of Potential Factors, Motivations, and Barriers Influencing Research Participation and Retention Among People Who Use Drugs in the Rural USA
Study examining research participation and retention among rural people who use drugs (PWUD) based on surveys of 255 research cohort members from Oregon, Kentucky, and Ohio. Examines participant demographics, drug use history, factors influencing research participation, and barriers and motivators related to research retention.
Author(s): Angela T. Hetrick, April M. Young, Miriam R. Elman, et al.
Citation: Trials, 22, 948
Date: 12/2021
Type: Document
view details
Study examining research participation and retention among rural people who use drugs (PWUD) based on surveys of 255 research cohort members from Oregon, Kentucky, and Ohio. Examines participant demographics, drug use history, factors influencing research participation, and barriers and motivators related to research retention.
Author(s): Angela T. Hetrick, April M. Young, Miriam R. Elman, et al.
Citation: Trials, 22, 948
Date: 12/2021
Type: Document
view details
Rural Opioid Treatment Program Patient Perspectives on Take-Home Methadone Policy Changes During COVID-19: A Qualitative Thematic Analysis
Study examining patient perspectives following policy changes in take-home methadone treatment for opioid use disorder (OUD), based on qualitative interviews with 46 patients from 3 rural opioid treatment programs in Oregon. Highlights main themes related to adapting to the changing policies during the COVID-19 pandemic, the challenges and benefits of at-home dosing, and future policy and procedural changes.
Author(s): Ximena A. Levander, Kim A. Hoffman, John W. McIlveen, et al.
Citation: Addiction Science & Clinical Practice, 16, 72
Date: 12/2021
Type: Document
view details
Study examining patient perspectives following policy changes in take-home methadone treatment for opioid use disorder (OUD), based on qualitative interviews with 46 patients from 3 rural opioid treatment programs in Oregon. Highlights main themes related to adapting to the changing policies during the COVID-19 pandemic, the challenges and benefits of at-home dosing, and future policy and procedural changes.
Author(s): Ximena A. Levander, Kim A. Hoffman, John W. McIlveen, et al.
Citation: Addiction Science & Clinical Practice, 16, 72
Date: 12/2021
Type: Document
view details
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Offers evidence-based information to support primary care providers in prescribing buprenorphine to treat opioid use disorder (OUD). Addresses strategies and considerations for primary care providers and practices looking to implement the treatment, including the phases of care, training and education, and payment and pharmacy considerations. Chapter 2.7 covers buprenorphine prescribing in rural settings.
Date: 12/2021
Type: Document
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Offers evidence-based information to support primary care providers in prescribing buprenorphine to treat opioid use disorder (OUD). Addresses strategies and considerations for primary care providers and practices looking to implement the treatment, including the phases of care, training and education, and payment and pharmacy considerations. Chapter 2.7 covers buprenorphine prescribing in rural settings.
Date: 12/2021
Type: Document
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Robustness of Estimated Access to Opioid Use Disorder Treatment Providers in Rural Vs. Urban Areas of the United States
Estimates level of access to opioid use disorder treatment at 31,053 locations in July 2020 for rural and urban opioid users by comparing drive time and availability of treatment. Discusses treatment disparities between rural and urban opioid users with particular focus on infrastructure such as transportation and broadband, hospital closures, and health insurance status.
Author(s): Matthew V. Kiang, Michael L. Barnett, Sarah E. Wakeman, Keith Humphreys, Alexander C. Tsai
Citation: Drug and Alcohol Dependence, 228, 109081
Date: 11/2021
Type: Document
view details
Estimates level of access to opioid use disorder treatment at 31,053 locations in July 2020 for rural and urban opioid users by comparing drive time and availability of treatment. Discusses treatment disparities between rural and urban opioid users with particular focus on infrastructure such as transportation and broadband, hospital closures, and health insurance status.
Author(s): Matthew V. Kiang, Michael L. Barnett, Sarah E. Wakeman, Keith Humphreys, Alexander C. Tsai
Citation: Drug and Alcohol Dependence, 228, 109081
Date: 11/2021
Type: Document
view details
Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond
Examines state-level policy data from government and nonprofit agencies related to treatment access and treatment retention for patients with Opioid Use Disorder (OUD) during the COVID-19 pandemic. Describes policy changes affecting telehealth coverage, delivery, and payment; issues of licensing and security; and the initiation and dispensing of treatment medications.
Author(s): Seema Chosky Pessar, Anne Boustead, Yimin Ge, Rosanna Smart, Rosalie Liccardo Pacula
Citation: JAMA Health Forum, 2(11), e213833
Date: 11/2021
Type: Document
view details
Examines state-level policy data from government and nonprofit agencies related to treatment access and treatment retention for patients with Opioid Use Disorder (OUD) during the COVID-19 pandemic. Describes policy changes affecting telehealth coverage, delivery, and payment; issues of licensing and security; and the initiation and dispensing of treatment medications.
Author(s): Seema Chosky Pessar, Anne Boustead, Yimin Ge, Rosanna Smart, Rosalie Liccardo Pacula
Citation: JAMA Health Forum, 2(11), e213833
Date: 11/2021
Type: Document
view details
COVID-19 and the Rural Opioid Epidemic: Recommendations to Improve Health in Illinois
Examines the rural opioid epidemic in Illinois and offers policy recommendations to increase access to Medications for Opioid Use Disorder (MOUD) centers, engaging populations involved with the criminal justice system, and expanding harm reduction services. Offers data on state opioid fatality rates with rural and urban comparisons and monthly mortality rates based on state Department of Public Health data. Discusses the impact of the COVID-19 pandemic on the opioid epidemic.
Date: 11/2021
Type: Document
Sponsoring organizations: SIU Medicine Center for Rural Health and Social Service Development, SIU Paul Simon Public Policy Institute, Southern Illinois University Medicine Department of Population Science and Policy, University of Illinois Chicago School of Public Health
view details
Examines the rural opioid epidemic in Illinois and offers policy recommendations to increase access to Medications for Opioid Use Disorder (MOUD) centers, engaging populations involved with the criminal justice system, and expanding harm reduction services. Offers data on state opioid fatality rates with rural and urban comparisons and monthly mortality rates based on state Department of Public Health data. Discusses the impact of the COVID-19 pandemic on the opioid epidemic.
Date: 11/2021
Type: Document
Sponsoring organizations: SIU Medicine Center for Rural Health and Social Service Development, SIU Paul Simon Public Policy Institute, Southern Illinois University Medicine Department of Population Science and Policy, University of Illinois Chicago School of Public Health
view details
Grantee Spotlight: Building Capacity for Tribal Health Providers to Deliver OUD Treatment in Rural Alaska
Profile features the Alaska Native Tribal Health Consortium and discusses its work supporting providers and organizations who provide treatment for opioid use disorder (OUD) in tribal communities in Alaska. Highlights some of the barriers to OUD treatment in rural Alaska and the methods used to overcome them.
Date: 11/2021
Type: Document
Sponsoring organizations: Alaska Native Tribal Health Consortium, Foundation for Opioid Response Efforts (FORE)
view details
Profile features the Alaska Native Tribal Health Consortium and discusses its work supporting providers and organizations who provide treatment for opioid use disorder (OUD) in tribal communities in Alaska. Highlights some of the barriers to OUD treatment in rural Alaska and the methods used to overcome them.
Date: 11/2021
Type: Document
Sponsoring organizations: Alaska Native Tribal Health Consortium, Foundation for Opioid Response Efforts (FORE)
view details
Improving Methadone Access for Rural Communities in the USA: Lessons Learned from Covid-19 Adaptations and International Models of Care
Explores the effect of changes to methadone treatment protocols for opioid use disorder in response to the COVID-19 pandemic on access to treatment in rural areas. Discusses telehealth, dispensing schedules, and distribution models before and during the pandemic.
Author(s): Jamey J Lister, Holly H Lister
Citation: Rural and Remote Health, 21(4)
Date: 11/2021
Type: Document
view details
Explores the effect of changes to methadone treatment protocols for opioid use disorder in response to the COVID-19 pandemic on access to treatment in rural areas. Discusses telehealth, dispensing schedules, and distribution models before and during the pandemic.
Author(s): Jamey J Lister, Holly H Lister
Citation: Rural and Remote Health, 21(4)
Date: 11/2021
Type: Document
view details
Long-acting Buprenorphine Injectables: Opportunity to Improve Opioid Use Disorder Treatment among Rural Populations
Explores a study on the potential effect long-acting buprenorphine injectables could have on access to treatment of opioid use disorder in rural areas. Discusses the functionality of the medication, as well as the different patient populations and healthcare settings that could potentially benefit from them.
Author(s): Michelle R.Lofwall, Laura C.Fanucchi
Citation: Preventive Medicine, 152(2), 106756
Date: 11/2021
Type: Document
view details
Explores a study on the potential effect long-acting buprenorphine injectables could have on access to treatment of opioid use disorder in rural areas. Discusses the functionality of the medication, as well as the different patient populations and healthcare settings that could potentially benefit from them.
Author(s): Michelle R.Lofwall, Laura C.Fanucchi
Citation: Preventive Medicine, 152(2), 106756
Date: 11/2021
Type: Document
view details